Statement of Changes in Beneficial Ownership (4)

Date : 09/11/2019 @ 9:32PM
Source : Edgar (US Regulatory)
Stock : Ampio Pharmaceuticals Inc (AMPE)
Quote : 0.399  0.0226 (6.00%) @ 5:00AM
After Hours
Last Trade
Last $ 0.39 ▼ -0.01 (-2.26%)

Statement of Changes in Beneficial Ownership (4)

FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

COELHO PHILIP H
2. Issuer Name and Ticker or Trading Symbol

Ampio Pharmaceuticals, Inc. [ AMPE ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__X__ Director                    _____ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

C/O AMPIO PHARMACEUTICALS, INC., 373 INVERNESS PARKWAY, SUITE 200
3. Date of Earliest Transaction (MM/DD/YYYY)

9/9/2019
(Street)

ENGLEWOOD, CO 80112
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy)  $1.70  8/27/2010    D        30000    (1) 8/27/2020  Common Stock  30000  $0  0  D 
 
Stock Option (Right to Buy)  $2.50  3/31/2011    D        150000    (2) 3/31/2021  Common Stock  150000  $0  0  D 
 
Stock Option (Right to Buy)  $2.76  5/7/2012    D        100000    (3) 5/7/2022  Common Stock  100000  $0  0  D 
 
Stock Option (Right to Buy)  $2.76  5/7/2012    D        75000    (4) 5/7/2022  Common Stock  75000  $0  0  D 
 
Stock Option (Right to Buy)  $3.46  12/20/2014    D        50000    (5) 12/20/2024  Common Stock  50000  $0  0  D 
 
Stock Option (Right to Buy)  $3.33  12/12/2015    D        30000    (6) 12/12/2025  Common Stock  30000  $0  0  D 
 
Stock Option (Right to Buy)  $0.75  9/9/2019    A     369750       (7) 9/9/2029  Common Stock  369750  $0  0  D 
 

Explanation of Responses:
(1)  This option was cancelled by mutual agreement between the company and the reporting person.
(2)  This option was cancelled by mutual agreement between the company and the reporting person.
(3)  This option was cancelled by mutual agreement between the company and the reporting person.
(4)  This option was cancelled by mutual agreement between the company and the reporting person.
(5)  This option was cancelled by mutual agreement between the company and the reporting person.
(6)  This option was cancelled by mutual agreement between the company and the reporting person.
(7)  100% of the stock options award vests and becomes exercisable on the date of the grant date.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
COELHO PHILIP H
C/O AMPIO PHARMACEUTICALS, INC.
373 INVERNESS PARKWAY, SUITE 200
ENGLEWOOD, CO 80112
X



Signatures
/s/ Phil Coelho 9/11/2019
**Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Ampio Pharmaceuticals (AMEX:AMPE)
Historical Stock Chart

1 Year : From Dec 2018 to Dec 2019

Click Here for more Ampio Pharmaceuticals Charts.

Ampio Pharmaceuticals (AMEX:AMPE)
Intraday Stock Chart

Today : Sunday 15 December 2019

Click Here for more Ampio Pharmaceuticals Charts.

Latest AMPE Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.